Technical Training and Executive Customer Visits Conducted in Saudi Arabia
In November 2017, CHIL conducted comprehensive on-site technical training and laboratory visits in Saudi Arabia as part of its ongoing…
CHIL Once Again at MEDICA
From November 13–16, 2017, CHIL participated in MEDICA Messe Düsseldorf in Düsseldorf, Germany. The exhibition provided an opportunity to review…
CHIL Expands to Central America
In September 2017, CHIL initiated its first export of diagnostic solutions to Panama, opening the company’s footprint in Central America.…
CHIL Participated in MEDLAB Asia Pacific 2017
CHIL participated in MEDLAB Asia Pacific from April 3–5, 2017, marking its first exhibition engagement focused on the Asia Pacific…
CHIL Participated in Medlab Middle East
From February 6–9, 2017, CHIL participated in Medlab Middle East in Dubai, one of the region’s leading laboratory and diagnostics…
CHIL Expanded Its Operations with Relocation to AOSB
On February 3, 2017, CHIL relocated its manufacturing operations from a 250 m² production area to a 1,000 m² facility…
Agreement Signed in KSA for Screening Project
On November 23, 2016, CHIL signed a notarized agreement with another leading company in the Kingdom of Saudi Arabia for…
CHIL Sustained Its International Presence at MEDICA
From November 14–17, 2016, CHIL participated in MEDICA Messe in Düsseldorf, Germany, continuing its consistent presence at one of the…
CHIL Entered the African and European Markets
During Arab Health 2016 in Dubai, CHIL held meetings with representatives from several African countries, resulting in principle agreements supporting…
CHIL’s High-Risk Group EIA Kits Recognized as Reference Assays in KSA Screening Program
CHIL’s high-risk group HIVAb, HBsAg, and HCVAb Enzyme Immunoassay (EIA) diagnostic kits have gained recognition as reference assays within a…